AMGN vs OLN · P/E 24, rev $36.75B vs rev $6.54B
Amgen Inc (AMGN) versus Olin Corporation (OLN) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Olin Corporation (OLN) is a chemicals company listed on NYSE.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported OLN revenue for 2024-12-31 was $6.54B. Net income was $105.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. OLN currently screens at market cap $2.62B.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. OLN currently screens at market cap $2.62B.
Not investment advice. Open the AMGN and OLN stock pages for the full models.
Not investment advice.